Search research articles
Contact Us
Filters
Showing results (1-10 of 622) with videos related to
Page
of 63
Sort By:
Biochemical Society Transactions
|
October 26, 2005
Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention
E A Eckman, C B Eckman
Neurologic Clinics
|
July 31, 2007
An update on the amyloid hypothesis
Christopher B Eckman, Elizabeth A Eckman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 26, 2006
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides
Feng Chen, Elizabeth A Eckman, Christopher B Eckman
Neurobiology of Aging
|
September 20, 2016
Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex
Javier Pacheco-Quinto, Christopher B Eckman, Elizabeth A Eckman
The Journal of Biological Chemistry
|
May 5, 2001
Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme
E A Eckman, D K Reed, C B Eckman
Current Opinion in Organ Transplantation
|
August 7, 2010
Immunosuppression in the sensitized heart transplant recipient
Peter M Eckman
JAMA
|
May 12, 1975
Brucellosis linked to Mexican cheese
M R Eckman
Journal of Thrombosis and Thrombolysis
|
September 7, 2015
Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation
Mark H Eckman
Journal of Neural Transmission. Supplementum
|
August 13, 1998
Presenilins and Alzheimer's disease: the role of A beta 42
C B Eckman
Hematology/Oncology Clinics of North America
|
December 1, 1996
Leg ulcers in sickle cell disease
J R Eckman
Page
of 63
Search research articles
Search
Showing results (1-10 of 622) with videos related to
Sort By:
Page
of 63
Biochemical Society Transactions
|
October 26, 2005
Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention
E A Eckman, C B Eckman
Neurologic Clinics
|
July 31, 2007
An update on the amyloid hypothesis
Christopher B Eckman, Elizabeth A Eckman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 26, 2006
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides
Feng Chen, Elizabeth A Eckman, Christopher B Eckman
Neurobiology of Aging
|
September 20, 2016
Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex
Javier Pacheco-Quinto, Christopher B Eckman, Elizabeth A Eckman
The Journal of Biological Chemistry
|
May 5, 2001
Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme
E A Eckman, D K Reed, C B Eckman
Current Opinion in Organ Transplantation
|
August 7, 2010
Immunosuppression in the sensitized heart transplant recipient
Peter M Eckman
JAMA
|
May 12, 1975
Brucellosis linked to Mexican cheese
M R Eckman
Journal of Thrombosis and Thrombolysis
|
September 7, 2015
Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation
Mark H Eckman
Journal of Neural Transmission. Supplementum
|
August 13, 1998
Presenilins and Alzheimer's disease: the role of A beta 42
C B Eckman
Hematology/Oncology Clinics of North America
|
December 1, 1996
Leg ulcers in sickle cell disease
J R Eckman
Page
of 63